3. Literature Review
3.1. Material and Methods
A systematic literature search and critical appraisal of the collected studies was conducted according to the Preferred Reporting Items for Systematic Review (PRISMA) standards. An electronic search was performed on PubMed from December 2022 to April 2023. The search terms were: ("intramural hematoma of the superior mesenteric artery” OR "intramural hematoma of visceral artery " OR "intramural hematoma of digestive artery" OR " intramural hematoma of aorta " OR "acute pulmonary haemorrhage" OR "acute pulmonary haemorrhage") AND ("idiopathic" OR "isolated" OR "acute" ) AND ("treatment" OR "corticosteroid treatment" OR "conservative treatment" OR "management" OR “immunological disease” OR “infective disease” “genetic disease” “autoimmune correlation”). The bibliographies of all identified articles were reviewed and cross-referenced to search for additional relevant literature. Methodological evaluation of each study was conducted according to PRISMA standards, including bias assessment.
Data collection involved study selection and data extraction. Articles with titles or abstracts relevant to our review were analyzed, and those studying the clinical presentations, disease management, outcomes, and pharmacological choices in conservative treatment were selected. A consensus process resolved disagreements on eligibility between researchers.
Unpublished, pre-print, or non-English language literature was excluded.
Other exclusion criteria were publications dated prior to 2000, no apparent correlation with the topic sought, generalization of IMH to non-visceral digestive districts (brain, upper or lower limbs), or districts of major interest (heart, aortic arch, ascending aorta, descending thoracic aorta, abdominal aorta). Data extraction was performed by two researchers and verified by two others.
3.2. Results
A review of the titles and abstracts and a manual search of the reference lists was carried out. The reference lists of all identified articles were reviewed to find missed-out papers. This search identified 48 articles screened after reading the full articles. Thirty-two articles were discarded as unrelated to the topic. The resulting 16 articles were screened to exclude duplicates and irrelevant papers. Four non-English papers and five papers published before 2000 were discarded after reading and analyzing based on the exclusion criteria.
The following inclusion criteria were used: (1) observational and retrospective and multicentric studies, (2) reviews and mini-reviews, and (4) case reports/series. These publications were carefully evaluated, considering the review's main aims. This evaluation left seven scientific papers comprising one observational study, three retrospective studies, and three case reports.
Of the seven articles, only two specifically address SIHSMA Three papers discuss the dissection of the SMA, with intramural hematoma described as a potential subset. Another paper presents a case report on intramural hematoma of the gastric artery, while the final article details a case report of multiple dissections and visceral intramural hematoma. The search strategy is depicted in
Figure 2 for clarity.
Figure 3.
Search strategy: a methodological appraisal of each study was conducted according to the PRISMA standards, including bias assessment. The data collection process included study selection and data extraction. (SIDSMA: spontaneous isolated dissection of superior mesenteric artery).
Figure 3.
Search strategy: a methodological appraisal of each study was conducted according to the PRISMA standards, including bias assessment. The data collection process included study selection and data extraction. (SIDSMA: spontaneous isolated dissection of superior mesenteric artery).
Fifty-five cases of superior mesenteric artery intramural hematoma were found in the explored database. The main characteristics of the articles included in this review are summarized in
Table 1. The studied population was composed of 10 females and 45 males. The main symptoms were gastrointestinal symptoms such as abdominal pain (83.63%), and few asymptomatic cases were found (16%). The main risk factors were recorded as the same in the vascular population: hypertension (19 patients), diabetes mellitus (2), smoke (8), coronary artery disease (5). No reference to genetic disease (Marfan syndrome or Ehlers-Danlos syndrome) or immunological disease was found. Laboratory analysis and instrumental analysis were not available in almost all cases.
Computer tomography angiography (CTA) was performed in all cases where instrumental data were reported. The IMH was described as the presence of a circular or crescent-shaped thickening of the aortic wall of >5 mm in the absence of detectable blood flow. It is classified according to their size and position along the SMA and the follow-up frequencies (
Table 2).
The screening of the updated literature revealed the effectiveness of conservative treatment in 76 percent of the patients. The progression of intramural hematoma to dissection or aneurysm was found in 5 patients (9%), in one case needing endovascular treatment after 1.5 months.
Six patients underwent endovascular treatment during the hospitalization for persistent abdominal pain symptoms, with only one needing open surgery.
There was no mention of using steroids or other therapeutics (as increasing antiplatelet therapy) as part of the conservative management, even in patients whose pain symptoms persisted (
Table 3).
4. Discussion
Spontaneous isolated intramural hematoma of the superior mesenteric artery (SIHSMA) is a rare, complex pathology to define and identify clinically.
The literature of the last 50 years discusses SIHSMA in relation to the isolated dissection of the superior mesenteric artery (SIDSMA). Only 27 cases of SIDSMA [
7] are described with an estimated incidence of less than 0.06% [
6]. Nevertheless, the superior mesenteric artery (SMA) is the most common incident site of isolated dissection among all digestive visceral arteries. SIDSMA predominantly affects male population (ratio 3:1) and the sixth-seventh decade of age (between 60 and 70 years) [
8].
With the increased use of CTA, which has enhanced the diagnosis of spontaneous isolated IMH and dissection, there has been a rise in the number of studies published concerning the management and clinical outcomes of both SISMAD and SIHSMA [
1,
8,
9,
10,
11].
Only two recent Asian studies [
1,
8] had specifically investigated the SIHSMA both observationally and retrospectively but with relatively short-term follow-up.
Some different authors as Li [
9], Sakamoto [
12], Yun [
13], and Yoo [
14] have suggested their classification of SIHSMA using similar criteria, such as the false lumens’ partial or complete thrombosis, the presence of penetrating ulcers, true lumen occlusion. However, there is still no standardized classification for SIHSMA.
The etiology of SIHSMA is still unclear; however, the presence of vascular wall inflammation has been hypothesized by some authors [
3,
15,
16] as the leading cause of intramural hematoma. There are multiple associations between IMH and artery dissection along with risk factors such as hypertension, arteriosclerosis, smoke, dyslipidemia, genetic diseases (Marfan’s disease, Elhers-Danlos disease), and systemic infections (mainly viral) as shown by the study of Nienaber from 2003 [
5]. Hypertension is considered the primary risk factor for IMH and dissection, in fact, it directly causes parietal stress on the vessel wall and indirectly activates proinflammatory agents during macrophage recruitment.
Based on the literature, intramural hematoma is recognized as a form of vascular wall inflammation. Given that the systemic inflammatory profile serves as a predictive factor for SIHSMA (akin to acute aortic syndrome), exploring all potential causes of systemic inflammatory disease is essential. This encompasses the examination of immunological, genetic, and infectious correlations to elucidate the multifactorial events in SISHMA.
The immunology department was consulted to examine all possible immunological profiles. Initially, the focus was on autoantibodies associated with the coagulation system, including Cardiolipin Antibodies, Beta-2 Glycoprotein 1 Antibodies, Antiphospholipid Antibodies (APA), and Lupus anticoagulants (LA). Subsequently, investigations were conducted for systemic autoimmune diseases using autoantibody tests such as antinuclear antibodies (ANA), extractable nuclear antigens (ENA), Anti-neutrophil Cytoplasmic Antibodies (ANCA), Anti-Double Stranded DNA (anti-dsDNA), Anticentromere Antibodies (ACA), Antihistone Antibodies, Cyclic Citrullinated Peptide Antibodies (CCP), Extractable Nuclear Antigen Antibodies (e.g., anti-SS-A (Ro) and anti-SS-B (La), anti-RNP, anti-Jo-1, anti-Sm, Scl-70), and Rheumatoid Factor (RF). All immunological tests, specific for coagulation and systemic inflammation, yielded negative results.
Genetic profiles were also examined, focusing on prevalent genetic pathologies in arterial diseases, including Marfan syndrome, Ehlers-Danlos disease, and Loeys-Dietz syndrome. In these instances, all tests yielded negative results. Consequently, no correlations between genetic or immunological factors were identified in any of the cases. In evaluating the inflammatory condition in SIHSMA patients as a potential infectious etiology, it was noted that none of the patients presented with pyrexia during their hospital stay. Comprehensive investigations were undertaken, encompassing blood cultures, urine tests, urine cultures, and a series of primary viral tests. These tests included immunoglobulin blood evaluations for varicella-zoster virus, measles, rubella, herpes simplex virus 1, herpes simplex virus 2, and cytomegalovirus. Notably, all these investigations returned negative results.
In the first patient, SARS-CoV-2 was considered as a potential primary inflammatory factor. Several authors have described the pathogenesis of coagulopathy associated with COVID-19 (CAC) as a predominant cause of COVID-19-related vasculopathy[
17,
18,
19,
20,
21,
22]. In this instance, the conventional risk factor, combined with systemic inflammation attributed to the SARS-CoV-2 virus, might provide a foundation for the proliferation of wall inflammation in the superior mesenteric artery. In subsequent cases, no discernible association was observed with their systemic inflammatory status.
Conservative management was opted for following the guidelines and classifying our patients as uncomplicated cases.
The ESVS guidelines [
23] for IMH and SIDSMA and the ACC/AHA guidelines [
24] for aortic suggest conservative management (Ia in ESVS; Ib-NR in ACC/AHA) in uncomplicated cases, with pressure control, anticoagulant/antiplatelet and analgesic drugs [
11,
25]. Hemodynamically unstable patients or presenting with complicated IMH/dissection need endovascular or open surgery vascular treatment (IIa ESVS). Besides, the studies of Xiao et al. [
6] and Wang et al [
1] which represent the most recent and complete studies about SIHSMA, suggest conservative management in hemodynamically stable patients with no progression of IMH in 87% of cases [
1] and complete remodeling in 62,5% of patients [
6]. Antiplatelet and anticoagulant drugs, analgesics, and pressure control as conservative management were used.
In this context, a conservative strategy was employed among the non-complicated patients identified in this study. This involved arterial pressure stabilization, pain management, and antiplatelet and anticoagulant therapy standardization. However, one patient from this cohort remained unresponsive to analgesic therapy and continued to report pain, necessitating the exploration of an alternative strategy.
Viewing SISHMA as a systemic inflammation devoid of immunological, genetic, or infectious associations and categorizing the two patients from this study as uncomplicated, the addition of corticosteroid drugs was deemed appropriate for conservative management. The optimal dosage and specific corticosteroids were selected in consultation with the immunology department for maximal efficacy against systemic inflammatory disease. A regimen of 25mg of prednisone was administered twice daily for a minimum of two months. Subsequently, the symptoms in the initial patient subsided.
Two months post-initiation of the treatment, a follow-up CTA was conducted and revealed complete resolution of the SIHSMA in both patients, with no residual vessel stenosis. Consequently, the decision was made to discontinue the therapy. Contrary to the guidelines recommending conservative treatment and suggesting potential IMH regression six months post-symptom onset, the case report presented here demonstrates complete IMH reabsorption just two months following the initiation of conservative treatment with corticosteroid drugs. Furthermore, as discussed in the Literature Review section, neither the specific SIHSMA studies by Xiao et al. [
6] and Wang et al [
1], nor any papers and reports from recent literature on visceral IMH or aortic IMH [
15,
25,
26,
27,
28,
29,
30,
31,
32,
33,
34,
35,
36,
37,
38,
39,
40,
41,
42,
43,
44,
45,
46] have documented the use of corticosteroids as a primary conservative treatment for intramural hematoma. This study represents the first instance of corticosteroids being considered an effective treatment for IMH of the superior mesenteric artery, deemed an "off-label treatment," with complete regression observed after two months. However, the findings are constrained by a limited sample size and data from a single institution. Additionally, the observation period was insufficient to ascertain the potential progression of IMH.